US2008029105A1PendingUtilityA1

Minimally-invasive devices and methods for treatment of congestive heart failure

Assignee: ETHICON INCPriority: Feb 22, 1993Filed: Mar 28, 2007Published: Feb 7, 2008
Est. expiryFeb 22, 2013(expired)· nominal 20-yr term from priority
A61B 2017/0496A61B 17/29A61B 2017/00247A61B 2090/306A61F 2007/0054A61B 17/0218A61B 2018/00982A61M 25/1011A61B 2017/0474A61B 2018/00363A61M 2039/0279A61B 2017/0475A61F 2/2445A61B 2017/2932A61M 1/3621A61B 2090/061A61B 2017/308A61B 17/0467A61B 2017/0243A61B 2017/00632A61B 2018/00291A61M 2202/047A61B 2017/2927A61B 2017/00907A61B 17/122A61M 39/0247A61B 2017/3492A61B 2018/00261A61F 7/10A61B 2017/00243A61B 2018/00214A61M 2025/028A61B 2018/00232A61B 17/3421A61F 2007/0001A61B 2017/047A61B 17/00234A61B 17/0293A61B 2018/00577A61B 2017/0237A61M 2205/3355A61F 2007/101A61B 2017/00053A61F 2/2442A61B 90/36A61B 18/1492A61B 17/06061A61M 2205/3344A61B 2017/2943A61B 2017/00946A61B 2017/306A61B 2017/2912A61B 90/50A61B 2017/3405A61B 2017/2926A61B 2017/0472A61M 2205/366A61M 2039/027A61B 17/0057A61B 2017/00867A61B 17/2909A61B 2017/00575A61B 2018/00392A61B 17/0469
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treatment of congestive heart failure comprises the steps of introducing an aortic occlusion catheter through a patient's peripheral artery, the aortic occlusion catheter having an occluding member movable from a collapsed position to an expanded position; positioning the occluding member in the patient's ascending aorta; moving the occluding member from the collapsed shape to the expanded shape after the positioning step; introducing cardioplegic fluid into the patient's coronary blood vessels to arrest the patient's heart; maintaining circulation of oxygenated blood through the patient's arterial system; and reshaping an outer wall of the patient's heart while the heart is arrested so as to reduce the transverse dimension of the left ventricle. The ascending aorta may be occluded and cardioplegic fluid delivered by means of an occlusion balloon attached to the distal end of an elongated catheter positioned transluminally in the aorta from a femoral, subclavian, or other appropriate peripheral artery.

Claims

exact text as granted — not AI-modified
1 . A method of reshaping a patient's heart comprising: 
 gauging the size of the left ventricle;    determining the amount by which the left ventricle should be reduced from the gauging of its size; and    reducing the dimension of the left ventricle in accordance with the determined amount.    
   
   
       2 . The method according to  claim 1 , wherein gauging the size of the left ventricle comprises encircling the heart closely with an adjustable length band, and determining the size of the ventricle with reference to the length of the band.  
   
   
       3 . The method according to  claim 1 , wherein gauging the size of the left ventricle comprises inserting an expansible member into the left ventricle, and expanding the expansible member.  
   
   
       4 . The method according to  claim 3 , wherein the expansible member is a balloon, and expanding the balloon is accomplished by the introduction of fluid into an interior of the balloon.  
   
   
       5 . The method according to  claim 4 , wherein gauging the size of the left ventricle further comprises measuring the volume of fluid introduced into the interior of the balloon.  
   
   
       6 . The method according to  claim 1 , wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.  
   
   
       7 . The method according to  claim 6 , wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.  
   
   
       8 . The method according to  claim 6 , wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.  
   
   
       9 . The method according to  claim 6 , wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.  
   
   
       10 . A method of reshaping a patient's heart comprising: 
 introducing an expansible member into the left ventricle of a patient's heart, the expansible member being at least partially collapsed;    expanding the expansible member within the left ventricle of a patient's heart; and    reducing the volume of the left ventricle by an amount based upon the expanded volume of the expansible member.    
   
   
       11 . The method according to  claim 10 , wherein the amount of volume reduction of the patient's left ventricle is determined by the expanded volume of the expansible member compared to a desired volume of the left ventricle.  
   
   
       12 . The method according to  claim 10 , wherein expanding the expansible member comprises the introduction of fluid into the interior of the expansible member.  
   
   
       13 . The method according to  claim 10 , wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.  
   
   
       14 . The method according to  claim 13 , wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.  
   
   
       15 . The method according to  claim 13 , wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.  
   
   
       16 . The method according to  claim 13 , wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.  
   
   
       17 . A method of reshaping a patient's heart comprising: 
 encircling the heart closely with an adjustable length band;    determining the size of the left ventricle with reference to the length of the band; and    reducing the volume of the left ventricle by an amount based upon the determined size of the left ventricle.    
   
   
       18 . The method according to  claim 13 , wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.  
   
   
       19 . The method according to  claim 13 , wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.  
   
   
       20 . The method according to  claim 13 , wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.  
   
   
       21 . The method according to  claim 13 , wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.

Join the waitlist — get patent alerts

Track US2008029105A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.